COMBINATIVE TREATMENT OF PATIENTS WITH BARRETT ESOPHAGUS
An experience in treatment of patients with gastroesophageal reflux diseasecomplicated by Barrett esophagus with the use of medication, endoscopic (argon-plasma ablation), and endosurgical (laparoscopic fundoplication) methods is reported. Complications observed in both the early and late postoperative periods are characterized.The preferred observation and therapeutic approaches are described, and directions on management of this category of patients are given. The paper analyzes the effect of argon-plasma ablation on mucosa and terms of the following surgical intervention -fundoplication.
Keywords
laparoscopic fundoplication,
intestinal meta,
plasia,
hiatal hernia,
gastroesophageal reflux disease,
argonplasma ablation,
лапароскопическая фундопликация,
Barrett esophagus,
грыжа пищеводного отверстия диафрагмы,
кишечная метаплазия,
гастроэзофагеальная рефлюксная болезнь,
аргонплазменная аблация,
ищевод БарреттаAuthors
Anischenko V. V. | | AVV1110@yandex.ru |
Platonov P. A. | | |
Всего: 2
References
Hamilton S.R., Smith R.R.L., Cameron J.L. Prevalence and characteristics ofBarrett esophagus in patients with adenocarcinoma of the esophagus oresophagogastric junction. Hum Pathol. 1998. - № 19. - Р. 942-948.
Cameron A. J., Lomboy C. T., Pera M., Carpenter H. A. Adenocarcinoma of theesophago-gastric junction and Barrett’s esophagus. Gastroenterology. 1995. - № 109. - Р. 1541-1546.
Давыдов М. И., Тер-Ованесов М. Д., Стилиди И. С. и др. Пищевод Барретта: от теоретических основ к практическим рекомендациям // Практическая онкология. - 2003. - Т. 4, № 2. - С. 109-119.
Harrison R., Perry I., Haddadin W. et al. Detection of intestinal metaplasia in Barrett’s esophagus: an observational comparator study suggests the needfor a minimum of eight biopsies / Am J Gastroenterol 2007; 102: 1154-1161.
Pohl H., Welch H. G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97:2:142-146.
Bremner C.G. Barrett’s esophagus. In DeMeester T.R., Matthews H.R. (eds):International Trends in General Thoracic Surgery. 1987. - V. 3: Benign Esophageal Diseases. St. Louis, CV Mosby. Р. 227-244.
Васильев Ю. В. Пищевод Барретта: этиопатогенез, диагностика, лечение больных // Трудный пациент. - 2006. - Т. 4, № 7. - С. 29-37.
Management of Barrett’s esophagus / The Society for Surgery of the Alimentary Tract (SSAT), American Gastroenterological Association (AGA), American Society for Gastrointestinal Endoscopy (ASGE) Consensus Panel // J. Gastrointest. Surg. - 2000. - V. 4, № 2. - Р. 115-116.
Guo J.P., Gilman P.B., Thomas R.M., Fisher R.S., Parkman H.P. Barrett’s esophagus and achalasia // J Clin Gastroenterol. - 2002 - V. 34, №. 4. - P. 439-443.
Мельченко Д. С., Белова Г. В. Пищевод Барретта: клинико-морфологические сопоставления // Медицинская визуализация. - 2006. - № 5. - С. 74-82. Вопросы реконструктивной и пластической хирургии № 4(51) декабрь, 2014 Анищенко В.В., Платонов П.А.
Cameron A. J. Epidemiology of columnarlined esophagus adenocarcinoma // Gastroenterol. Clin. NorthAmer. - 1997. - V. 26. - P. 487-494.
DeVault K.R. Epidemiology and significance of Barrett’s esophagus / /Dig. Dis. - 2001. - V. 18, № 4. - Р. 195-202.
Dvorakova K., Payne C.M., Ramsey L. et al. Apoptosis resistance in Barrett’s esophagus: ex vivo bioassay of live stressed tissues // Am J Gastroenterol. - 2005 - V. 100, №. 2. - P. 424-431.
Cossentino M.J., Wong R.K. Barrett’s esophagus and risk of esophageal adenocarcinoma // Semin. Gastrointest. Dis. - 2003. - V. 14, № 3. - Р. 128-135.